Changes to the EU Pharmacovigilance System
LEGISLATIVE CHANGES TO THE EU PHARMACOVIGILANCE SYSTEM
The European Commission announced its intention to introduce the most significant re-design of the EU’s Pharmacovigilance (PV) system in the last 40 years. Following a recent public consultation, the Commission aims to significantly strengthen and rationalize the system, in order to make it appropriate for an enlarged EU with innovative products, modern information technology and study designs.
Learn more about these changes by filling out the form below.
INFORMATION REQUEST
